All PlansCoverageMedium impact
Drug Policy Criteria Change
Arkansas Blue Cross Blue Shield·Pharmacy·Pharmacy
Effective date
Jul 1, 2026
We identified it
Jun 25, 2026
Summary
Tyruko (a retail drug) is transitioning from non-formulary to formulary coverage effective July 1, 2026. This means the drug will now be a covered benefit under formulary guidelines, potentially reducing patient out-of-pocket costs and changing claim adjudication requirements.
Action Required
By June 1, 2026: Billing and clinical teams must update formulary references and pharmacy benefit management (PBM) systems to reflect Tyruko as a formulary drug. Review patient records and claims for Tyruko prescriptions written before the effective date—these may still require non-formulary billing. Communicate the change to prescribers to ensure new prescriptions after 07/01/2026 reference the formulary status. Rebill any recent denied claims for Tyruko as non-formulary coverage transitions to formulary to recover potential reimbursement differences.